Imunon, Inc.

IMNN · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 20 employees
401
SEC Filings
$2.15
Close 2026-06-01
20
Employees

Business Summary

1 FORWARD-LOOKING STATEMENTS 1 OVERVIEW 2 THERAPLAS MODALITY: IMNN-001 DEVELOPMENT PROGRAM 2 Ovarian Cancer Overview 2 IMNN-001 Immunotherapy 3 OVATION I Study 3 OVATION 2 Study 5 OVATION 3 Study 8 IMNN-001 in Combination with Bevacizumab 9 PLACCINE DNA VACCINE MODALITY: IMNN-101 9 Our Next Generation Vaccine Initiative 10 BUSINESS STRATEGY AND DEVELOPMENT PLAN 12 RESEARCH AND DEVELOPMENT EXPENDITURES 13 GOVERNMENT REGULATION 14 MANUFACTURING AND SUPPLY 24 SALES AND MARKETING 24 PRODUCT LIABILIT...

Latest Stock Quote

IMNN 2026-06-01 $2.15 O:$2.17 H:$2.26 L:$2.0987 Vol:0.1M VWAP:$2.18
origin leaf: a0e32d24a77a1fe00985d3d94af95d8b4ffceabc9dbbee82405a43cbb62a2695

Next Earnings

Q2 FY2026 — expected 2026-08-18

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001493152-26-013850EDGAR74K words
2025-02-272024-12-310001493152-25-008460EDGAR—
2024-03-282023-12-310001493152-24-011616EDGAR—
2023-03-302022-12-310001493152-23-009604EDGAR—
2022-03-312021-12-310001493152-22-008277EDGAR—
2021-03-192020-12-310001493152-21-006382EDGAR—
2020-03-252019-12-310001493152-20-004717EDGAR—
2019-03-292018-12-310001493152-19-004184EDGAR—
2018-03-272017-12-310001437749-18-005539EDGAR—
2017-03-242016-12-310001437749-17-005235EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001493152-25-022120EDGAR26K words
2025-08-052025-06-300001493152-25-011598EDGAR—
2025-05-122025-03-310001641172-25-009572EDGAR—
2024-11-072024-09-300001493152-24-043931EDGAR—
2024-08-142024-06-300001493152-24-031916EDGAR—
2024-05-132024-03-310001493152-24-018795EDGAR—
2023-11-142023-09-300001493152-23-040803EDGAR—
2023-08-102023-06-300001493152-23-027457EDGAR—
2023-05-112023-03-310001493152-23-016299EDGAR—
2022-11-142022-09-300001493152-22-031641EDGAR—
2022-08-152022-06-300001493152-22-022599EDGAR—
2022-05-162022-03-310001493152-22-013522EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001493152-26-013816EDGAR3K words
2026-03-230001493152-26-012164EDGAR—
2026-02-050001493152-26-005203EDGAR—
2026-01-070001493152-26-000841EDGAR—
2025-12-310001493152-25-029711EDGAR—
2025-11-130001493152-25-022118EDGAR—
2025-08-280001493152-25-012417EDGAR—
2025-08-050001493152-25-011597EDGAR—
2025-07-280001493152-25-011440EDGAR—
2025-07-230001641172-25-020652EDGAR—

401 total filings indexed. 369 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0000749647
TickerIMNN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.imunon.com
Listed1995-07-24

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 890197e468c1146d99b028a6c145c8c855f4e92be7d35e5f966a29bced51c95c
parent: fa60f3a92bbf6869b19c9e8416d83ee9563551c7305cd737e85fa19e6686dfad
content hash: 9b5953345c52b783ff84968496cee0c97c80653926906d66ce03e39801d008bb
signed: 2026-06-02T19:01:30.615Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf